ClinConnect ClinConnect Logo
Search / Trial NCT06791837

Brain Blood Flow and Lactate in Non-obese and Obese Subjects

Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Jan 19, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Lactate Obesity Exercise

ClinConnect Summary

This clinical trial is studying how a substance called lactate, which the body produces during exercise, affects blood flow to the brain in people with and without obesity. Researchers want to understand if higher levels of lactate can improve brain health and function, especially since reduced blood flow to the brain can lead to serious issues like memory loss and conditions such as Alzheimer’s disease. The trial will also explore if short exercise sessions can help people with obesity manage their lactate levels better.

To be eligible for this study, participants should be healthy adults aged 18 to 45, with a body mass index (BMI) between 18 and 40. Women must be premenopausal and not pregnant or breastfeeding. There are some health conditions, medications, and recent health events that could prevent someone from participating, so it’s important for potential volunteers to discuss their health history with the researchers. If chosen, participants can expect to take part in exercises and tests that will help scientists learn more about the relationship between lactate, exercise, and brain blood flow.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • healthy adult men and women 18-45 years of age BMI 18-40 kg/m2 not pregnant, premenopausal with regular menstrual cycles not breastfeeding non-nicotine users
  • Exclusion Criteria:
  • medications known to affect sleep, autonomic control, blood lactate levels or metabolic, or cardiovascular function (PI discretion) self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse major cardiovascular event or surgical procedure within the past three months hypertension (\>140/90 mmHg or at PIs discretion).
  • -

About University Of Missouri Columbia

The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.

Locations

Columbia, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Jill Kanaley, PhD

Principal Investigator

University of Missouri-Columbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported